XML 29 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2019
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Measurement
The following tables represent the financial instruments measured at fair value on a recurring basis in the financial statements of the Company and the valuation approach applied to each class of financial instruments at September 30, 2019 and December 31, 2018 (in thousands):

 
September 30, 2019
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
69,750

$

$

$
69,750

Total cash and cash equivalents
$
69,750

$

$

$
69,750

Investments:
 
 
 
 
Certificates of deposit

4,183


4,183

U.S. Treasury securities
12,001



12,001

U.S. Agency securities

1,505


1,505

Asset-backed securities

1,107


1,107

Corporate notes and bonds

10,182


10,182

Total investments
12,001

16,977


28,978

Total assets measured at fair value
$
81,751

$
16,977

$

$
98,728


 
December 31, 2018
 
Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)
Significant
Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
 
 
 
 
Cash and cash equivalents:
 
 
 
 
Money market funds
$
38,444

$

$

$
38,444

Commercial paper

1,493


1,493

Total cash and cash equivalents
38,444

1,493


39,937

Investments:
 
 
 
 
Certificates of deposit

10,787


10,787

U.S. Treasury securities
22,120



22,120

U.S. Agency securities

7,980


7,980

Commercial paper

17,025


17,025

Asset-backed securities

11,998


11,998

Corporate notes and bonds

30,308


30,308

Total investments
22,120

78,098


100,218

Total assets measured at fair value
$
60,564

$
79,591

$

$
140,155